Evaxion CEO Departs; CFO and Interim CEO Appointed

Dow Jones
07/01
 

By Denny Jacob

 

Evaxion said Chief Executive Christian Kanstrup has stepped down and that a search for its next leader is under way.

The clinical-stage tech-bio company said Chief Scientific Officer Birgitte Rønø was appointed interim CEO. Rønø has been with Evaxion since 2017 and joined its executive management in 2021.

Additionally, Thomas Schmidt was named permanent chief financial officer after joining the company in November as interim CFO.

 

Write to Denny Jacob at denny.jacob@wsj.com

 

(END) Dow Jones Newswires

July 01, 2025 08:46 ET (12:46 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10